跳至主要内容
临床试验/EUCTR2015-004959-50-ES
EUCTR2015-004959-50-ES进行中(未招募)1 期

HELIOX-DRIVEN BETA2-AGONISTS NEBULIZATION FOR CHILDREN WITH MODERATE TO SEVERE ACUTE ASTHMA: A RANDOMIZED CONTROLLED TRIA

S.E. Carburos Metálicos S.A. grupo Air Products0 个研究点目标入组 54 人开始时间: 2015年12月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All inclusion criteria are:
  • (1)All participants or their parents or guardians will give their informed written consent to participate.
  • (2) Age 6-16 years.
  • (3) Diagnosis of asthma according to the guidelines.
  • (4) Patients attending to an ED for an acute exacerbation.
  • (5) Pulmonary score of = 4
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 58
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • (1) Altered consciousness.
  • (2) Pulse oximetry reading of less than 90%
  • (3) Systolic blood pressure greater than 180 mm Hg,
  • (4) Patients requiring non-invasive ventilation, or intubation and/or mechanical ventilation.
  • (5) Other concomitant diseases than asthma.
  • (6) Be treated with corticosteroids until 6 hours before

研究者

发起方
S.E. Carburos Metálicos S.A. grupo Air Products

相似试验

HELIOX-DRIVEN BETA2-AGONISTS NEBULIZATION FOR... | 临床试验